RECURSION PHARMACEUTICALS INC. - CLASS A COMMON S
7.2600
08-يناير-25 16:45:00
15 متأخرة بدقائق
الأسهم
-0.2300
-3.07%
نطاق اليوم
6.9800 - 7.4100
ISIN
N/A
المصدر
NASDAQ
-
24 يونيو 2024 08:00:00 بحسب Nasdaq GlobeNewswire
-
Recursion to Participate in Upcoming Investor Conferences
03 يونيو 2024 09:00:00 بحسب Nasdaq GlobeNewswire
-
29 مايو 2024 15:27:37 بحسب Nasdaq GlobeNewswire
-
Recursion Appoints Robert Hershberg M.D., Ph.D, as New Chair of the Board
24 مايو 2024 16:30:00 بحسب Nasdaq GlobeNewswire
-
13 مايو 2024 05:00:00 بحسب Nasdaq GlobeNewswire
-
Recursion Provides Business Updates and Reports First Quarter 2024 Financial Results
09 مايو 2024 16:01:00 بحسب Nasdaq GlobeNewswire
-
Recursion to Report First Quarter 2024 Business Updates and Financial Results on May 9
02 مايو 2024 08:00:00 بحسب Nasdaq GlobeNewswire
-
Recursion to Participate in Upcoming Investor Conferences
01 مايو 2024 08:01:00 بحسب Nasdaq GlobeNewswire
-
30 أبريل 2024 08:00:01 بحسب Nasdaq GlobeNewswire
-
Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer
16 أبريل 2024 08:00:00 بحسب Nasdaq GlobeNewswire
-
Recursion to Participate in Upcoming Investor Conference
02 أبريل 2024 08:00:00 بحسب Nasdaq GlobeNewswire
-
Recursion Publishes Annual Environmental, Social and Governance Report
26 مارس 2024 08:00:00 بحسب Nasdaq GlobeNewswire
-
Recursion Announces Plans to Open New Office in London
11 مارس 2024 04:00:00 بحسب Nasdaq GlobeNewswire
-
Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community
01 مارس 2024 14:58:00 بحسب Nasdaq GlobeNewswire
-
Recursion to Participate in Upcoming Investor Conferences
01 مارس 2024 07:59:00 بحسب Nasdaq GlobeNewswire
-
27 فبراير 2024 16:05:11 بحسب Nasdaq GlobeNewswire
-
Recursion to Host Public L(earnings) Call on February 27
20 فبراير 2024 07:59:00 بحسب Nasdaq GlobeNewswire
-
Altitude Lab Startups Raise Over $120M in Capital
24 يناير 2024 09:00:00 بحسب Nasdaq GlobeNewswire
-
Recursion Unveils LOWE Drug Discovery Software at the J.P. Morgan Healthcare Conference
08 يناير 2024 10:59:00 بحسب Nasdaq GlobeNewswire
-
Recursion Adds New Chemical Entity Targeting Fibrotic Diseases to Late Discovery Pipeline
04 يناير 2024 07:59:00 بحسب Nasdaq GlobeNewswire